ScPharmaceuticals develops pharmaceutical products designed for subcutaneous delivery, addressing the need for more efficient and patient-friendly administration of medications. Their technology aims to enhance drug absorption and improve patient compliance, reducing the reliance on intravenous therapies.
Funding
Funding not disclosed
Founders
Product
Problem
Many medications are traditionally administered intravenously, requiring patients to visit a clinic or hospital, which can be inconvenient and costly. This reliance on IV therapies can also lead to complications such as infections and increased healthcare resource utilization.
Solution
scPharmaceuticals develops and commercializes pharmaceutical products designed for subcutaneous delivery, offering a more convenient and patient-friendly alternative to intravenous administration. Their technology aims to enhance drug absorption and improve patient compliance by enabling patients to self-administer medications at home or in other non-clinical settings. This approach reduces the need for frequent clinic visits, lowers healthcare costs, and minimizes the risks associated with IV therapies. By shifting the site of care, scPharmaceuticals seeks to improve the overall patient experience and outcomes.
Target Audience
The primary target audience includes patients requiring frequent or chronic medication administration, healthcare providers seeking to reduce the burden of IV therapies, and healthcare systems aiming to lower costs and improve patient outcomes.
Features
- Subcutaneous delivery system for convenient self-administration of medications.
- Enhanced drug absorption through proprietary formulation technology.
- Reduced reliance on intravenous therapies and associated complications.
- Improved patient compliance due to ease of use and accessibility.